SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-14-000165
Filing Date
2014-01-13
Accepted
2014-01-13 06:45:17
Documents
16
Period of Report
2014-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_011314.htm 8-K 19714
2 EXHIBIT 99.1 exh_991.htm EX-99.1 13194
3 exh991_01.jpg GRAPHIC 241074
4 exh991_02.jpg GRAPHIC 165864
5 exh991_03.jpg GRAPHIC 193870
6 exh991_04.jpg GRAPHIC 241925
7 exh991_05.jpg GRAPHIC 184157
8 exh991_06.jpg GRAPHIC 213304
9 exh991_07.jpg GRAPHIC 261571
10 exh991_08.jpg GRAPHIC 249216
11 exh991_09.jpg GRAPHIC 227611
12 exh991_10.jpg GRAPHIC 215946
13 exh991_11.jpg GRAPHIC 250191
14 exh991_12.jpg GRAPHIC 142520
15 exh991_13.jpg GRAPHIC 219160
16 exh991_14.jpg GRAPHIC 174158
  Complete submission text file 0001171843-14-000165.txt   4142232
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 14523158
SIC: 2834 Pharmaceutical Preparations